How comparing works here
How do I compare two companies?
Type the tickers into the box above — up to five at once. Every row is read from the companies' own annual filings, so a comparison shows the same measure computed the same way for each of them rather than whatever each company chose to highlight.
Can I compare an ETF with a stock?
Yes, and the table changes to suit. Two funds are compared on cost, income, spread and record, because revenue growth and debt mean nothing for a fund. A fund against a company shows only what both of them have.
Side by side
Compare
Put up to 4 companies, funds, commodities or coins next to each other — health, valuation, growth and performance.
Every row is computed the same way for every column, from each company's own annual filing, so a comparison is not a collection of whichever figures each of them chose to put in a press release. Funds are compared on what a fund is actually judged on: cost, income, spread and record.
Relative performance
Rebased so every symbol starts at 0%
Loading price history…
Side by side
Latest annual figures from each company's filings
| Metric | MMEDMiniMed Group, Inc. | COOCOOPER COMPANIES, INC. | ALGNALIGN TECHNOLOGY INC | LNTHLantheus Holdings, Inc. | Median of the restexcluding MMED |
|---|---|---|---|---|---|
| Type | Company | Company | Company | Company | |
| Price | $18.29▲ 0.49 (2.75%) | $61.65▲ 2.68 (4.54%) | $155.51▲ 4.14 (2.74%) | $100.10▼ 0.14 (0.14%) | |
| Health scoreComposite of profitability, growth, debt and accounting quality. | 6.0/10 | 7.0/10 | 8.7/10 | 9.0/10 | 8.7/10 |
| Market value | $5.14B | $12.08B | $11.10B | $6.47B | |
| Revenue | $3.10B | $4.09B | $4.03B | $1.54B | |
| Profit | -$333.0M | $374.9M | $410.4M | $233.6M | |
| Revenue growthChange in sales versus the prior year. | 14.3% | 5.1% | 0.9% | 0.5% | 0.9% |
| Gross marginShare of sales left after the direct cost of producing them. | 54.2% | 65.5% | 67.2% | 61.1% | 65.5% |
| Operating marginShare of sales left after running the business, before interest and tax. | -6.1% | 16.7% | 13.5% | 20.2% | 16.7% |
| Profit marginProfit kept from each dollar of sales. | -10.7% | 9.2% | 10.2% | 15.2% | 10.2% |
| Free cash flow marginCash left after capital spending, as a share of sales. | -13.5% | 10.6% | 12.2% | 23.0% | 12.2% |
| Return on equityProfit against the owners' stake in the company. | -9.2% | 4.6% | 10.1% | 21.4% | 10.1% |
| Return on invested capital (approx.)Operating profit after tax against equity plus debt, less cash. Cash here excludes short-term investments, so this runs low for cash-rich companies. | -4.5% | 4.3% | 13.0% | 17.8% | 13.0% |
| P/E ratioPrice paid per dollar of annual profit. | — | 32.21x | 27.04x | 27.68x | 27.68x |
| EV / EBITDA (approx.)Market value plus debt less cash, against operating profit before depreciation. Cash excludes short-term investments, so this runs high for cash-rich companies. | — | 13.65x | — | 17.52x | 15.59x |
| Price to book | 1.42x | 1.47x | 2.74x | 5.93x | 2.74x |
| Debt to equityTotal liabilities compared with owners' stake. | 0.28x | 0.50x | 0.54x | 1.04x | 0.54x |
| Piotroski F-ScoreNine checks of financial strength. Higher is stronger. | 3/8 | 6/9 | 6/8 | 5/9 | 6.0 |
| Bankruptcy riskAltman Z-Score zone. | safe | safe | safe | safe |
How MMED compares with the others
- MMED's operating margin of -6.1% is lower than the median of the other companies selected (16.7%).
- Its revenue grew faster than the median of the other companies selected: 14.3% against 0.9%.
- It has no P/E to set against theirs, because it did not make a profit.
- Its liabilities are lower relative to equity than the median of the other companies selected: 0.3x against 0.5x.
Measured against the other companies entered, from each one's latest annual filing. A difference describes the companies; it does not rank them.